Kelley Robert J. 4
4 · Talis Biomedical Corp · Filed Dec 9, 2021
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-08+450,000→ 450,000 totalExercise: $4.28Exp: 2031-12-07→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.